Canada markets close in 3 hours 14 minutes

FSD Pharma Inc. (0K9A.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
2.7900-0.5960 (-17.60%)
As of 5:10PM CEST. Market open.
Full screen
Previous Close3.3860
Open2.7900
Bid2.5960 x N/A
Ask2.8600 x N/A
Day's Range2.7900 - 2.7900
52 Week Range2.3480 - 17.0452
Volume1,000
Avg. Volume1,456
Market Cap29.344M
Beta (5Y Monthly)0.59
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • FSD Pharma Inc., Developing its PEA Compound to Treat COVID-19, CEO Clip Video
    Newsfile

    FSD Pharma Inc., Developing its PEA Compound to Treat COVID-19, CEO Clip Video

    Vancouver, British Columbia--(Newsfile Corp. - July 31, 2020) - FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) CEO and Chairman, Raza Bokhari speaks about the company's lead Compound, PEA, to treat COVID-19.If you cannot view the video above, please visit:https://www.b-tv.com/fsd-pharma-compound-to-treat-covid-19-ceo-clip-90sec/FSD Pharma will air on BIZTV throughout the month of August 2020, throughout the day and evenings.FSD Pharma Inc. (CSE: HUGE) (NASDAQ: HUGE) fsdpharma.comAbout CEO Clips:CEO Clips is the largest library of publicly traded company CEO ...

  • ACCESSWIRE

    FSD Pharma Inc. Announces US$10 Million Registered Direct Offering

    TORONTO, ON / ACCESSWIRE / July 31, 2020 / FSD Pharma Inc.

  • FSD Pharma Announces Decision to Surrender Health Canada Licenses for Subsidiary FV Pharma Inc.
    Business Wire

    FSD Pharma Announces Decision to Surrender Health Canada Licenses for Subsidiary FV Pharma Inc.

    FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) (FRA: 0K9A) ("FSD Pharma" or the "Company") today announced that it has notified Health Canada of the Company’s decision to forfeit the licenses of its wholly-owned subsidiary, FV Pharma, Inc. ("FV Pharma") and suspend all activities by FV Pharma within 30 days of the notification date. FSD Pharma has begun the process of liquidating all FV Pharma assets, including the sale of the Company’s cannabis production facility in Cobourg, Ontario.